| |
|
| |
| Контактная | ООО Нинбоская Компания
Фармацевтических Химикатов
«Инно» Адрес :11-ый этаж, Здание Хайгуан, №.298, Чжуншаньсилу, г. Нинбо Т е л. : 86-574-27787657 87319282 87314919 Факс. : 86-574-27912196 56877908 Веб-сайт:www.innopharmchem.com |
|
| |
|
|
|
|
 |
|
 |
| |
| Cilostazol |
| |
Chemical Name:6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone Additional name
Molecular Formula:C20H27N5O2
Structural Formula:
CAS:73963-72-1
Physicochemical Property:White to pale yellow-white crystalline powder
Quality Standard(GMP):Tests Item | Standard | Appearance | White to pale yellow-white crystalline powder | Identification | Complies with the test | Melting point | 158℃～162℃ | Residue on ignition | NMT0.10% | Loss on drying | NMT0.30% | Heavy metal | NMT10ppm | Chloride | NMT0.018% | Single impurity | NMT0.20% | Total impurities | NMT1.0% | Assay (HPLC) | 98.5.0%~101.5% |
Package:20kg/drum
Usage:For treat atherosclerosis, arteritis, thromboangiitis obliterans, diabetes caused by chronic arterial occlusive disease; to improve limb ischemia caused by chronic ulcers, pain, chills, and intermittent claudication, and can be used as a Surgical treatment of these diseases (such as angioplasty, vascular grafting, sympathectomy) after replacement therapy to alleviate the symptoms.
Storage:Shading, sealing preservation.
|
|
| |
|
|
|
|
